Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Catabasis Pharma Cmn (CATB)

1.2152 -0.0248 (-2.0000%)

2/28/2017  11:24am

Open:

1.2300

Pre. Close:

1.2400

High:

1.2300

Low:

1.2001

Volume:

86,529

Market Cap:

22.67M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.27 - 1.31

1.31 - 1.32

Low:

1.03 - 1.12

1.12 - 1.15

Close:

1.13 - 1.23

1.23 - 1.26

Technical analysis  (as of: 2017-02-28 11:39:28 AM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 4.09     One year: 5.84

Support:

Support1: 1.08    Support2: 0.90

Resistance:

Resistance1: 3.50    Resistance2: 5.00

Pivot:

1.23

Moving Averages:

MA(5): 1.21     MA(20): 1.37

MA(100): 3.54     MA(250): 4.35

MACD:

MACD(12,26): -0.55     Signal(12,26,9): -0.63

%K %D:

%K(14,3): 27.71     %D(3): 27.30

RSI:

RSI(14): 26.56

52-Week:

High: 8.1500  Low: 1.0800  Change(%): -72.5

Average Vol(K):

3-Month: 533  10-Days 389

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CATB has closed above bottom band by 24.0%. Bollinger Bands are 96.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to CATB's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 01 Feb 2017 10:52:30 GMT
Catabasis Pharmaceuticals Inc (NASDAQ:CATB): What's Next?

Thu, 19 Jan 2017 14:08:44 GMT
Catabasis Pharma surges 17% on positive early-stage clinical trial results for ...

Fri, 17 Feb 2017 12:56:15 GMT
Catabasis Pharmaceuticals Announces Promotion of Ted Hibben to Chief Business ...

Mon, 27 Feb 2017 16:02:44 GMT
Catabasis Pharmaceuticals, Inc. (CATB) Receives $8.25 Average PT from Brokerages

Wed, 08 Feb 2017 03:45:00 GMT
Svlsf V, Llc. is Buying Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Shares

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

18.65

Shares Float (M)

8.58

% Held by Insiders

4.20

% Held by Institutions

83.30

Shares Short (K)

529

Shares Short Prior Month (K)

275

Stock Financials

EPS

-2.400

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.980

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-36.9

Return on Equity (ttm)

-76.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.922

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.62

Levered Free Cash Flow (M)

-20.90

FoxReading.com

Valuation

P/E

-0.50

P/E Growth Ratio

-0.02

P/BV

0.61

P/S

P/CF

-0.67

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.